Protein Corona Formation on Soft Nanocarriers Under Biomimetic Circulatory Flow
Source abstract
Abstract
ABSTRACT Upon exposure to biological fluids, nanoparticles are rapidly coated by a layer of adsorbed proteins known as the protein corona (PC). PC composition strongly influences the nano‐bio interactions, yet its formation under physiologically relevant flow remains insufficiently explored. Here, a venous circulation‐mimicking system is designed to replicate physiological shear forces and dynamic protein exchange encountered during intravenous administration. PC formation on commonly utilized soft nanocarriers, including liposomes, poly(lactic‐ co ‐glycolic acid) nanoparticles (PLGA NPs), and lipid‐polymer hybrid nanoparticles (LPNPs) is investigated under biomimetic flow. The results demonstrate that flow‐induced PC formation alters the physicochemical properties of nanocarriers in a nanocarrier type‐dependent manner. Proteomic PC profiling reveals a largely shared protein core among all nanocarriers, alongside distinct material‐specific protein signatures. Uptake studies in A549 cells show that PC formation markedly reduces nanocarrier uptake for all formulations, indicating that pre‐formed coronas persistently modulate nanoparticle‐cell interactions. These findings highlight the central role of PC formation in defining nanocarrier biological identity and demonstrate that biomimetic circulation modulates corona organization without overriding serum‐driven effects. This study highlights the importance of incorporating dynamic and physiologically relevant conditions into in vitro models to better understand and evaluate nanocarrier behavior, and guide the rational design of nanomedicine platforms.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Group of Biointerfaces Institute of Chemistry and Bioanalytics School of Life Sciences University of Applied Sciences and Arts Northwestern Switzerland Muttenz Switzerland
Department of Chemistry University of Basel Basel Switzerland
Swiss Nanoscience Institute University of Basel Basel Switzerland
Group of Data Science in Life Sciences Institute of Chemistry and Bioanalytics School of Life Sciences University of Applied Sciences and Arts Northwestern Switzerland Muttenz Switzerland
Funding
Swiss Nanoscience Institute
References (52)
Show source-provided references
1. Biomolecular Coronas Provide the Biological Identity of Nanosized Materials10.1038/nnano.2012.207 ↗
2. Understanding the Nanoparticle–Protein Corona Using Methods to Quantify Exchange Rates and Affinities of Proteins for Nanoparticles10.1073/pnas.0608582104 ↗
3. Understanding and Controlling the Interaction of Nanomaterials With Proteins in a Physiological Environment10.1039/C1CS15233E ↗
4. Zanganeh S. · 2018 · 9110.1016/B978-0-08-101925-2.00011-5 ↗
5. Protein−Nanoparticle Interactions: Opportunities and Challenges10.1021/cr100440g ↗
6. Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses10.3390/nano12040682 ↗
7. Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake10.1021/acs.biomac.5b00108 ↗
8. Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties10.1021/acsnano.6b00261 ↗
9. Effects of Liposome Composition and Size on Protein Corona Formation: Competitive Replacement of Abundant Proteins by High‐Affinity Proteins on the Liposome Surface
10. Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids10.1038/196476a0 ↗
11. Merging Worlds of Nanomaterials and Biological Environment: Factors Governing Protein Corona Formation on Nanoparticles and Its Biological Consequences10.1186/s11671-015-0922-3 ↗
12. Hard and Soft Protein Corona of Nanomaterials: Analysis and Relevance10.3390/nano11040888 ↗
13. The Distribution of Complement Proteins in Soft and Hard Coronas Impacts Macrophage Uptake of Nanoparticles
14. Nanoparticle Size and Surface Properties Determine the Protein Corona With Possible Implications for Biological Impacts10.1073/pnas.0805135105 ↗
15. Nanoparticle Size is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis10.1021/nn201950e ↗
16. Chemical and Biophysical Signatures of the Protein Corona in Nanomedicine10.1021/jacs.2c02277 ↗
17. Understanding the Chemical Nature of Nanoparticle–Protein Interactions10.1021/acs.bioconjchem.9b00348 ↗
18. Significance of Surface Charge and Shell Material of Superparamagnetic Iron Oxide Nanoparticle (SPION) Based Core/Shell Nanoparticles on the Composition of the Protein Corona10.1039/C4BM00264D ↗
19. Optimizing the Properties of the Protein Corona Surrounding Nanoparticles for Tuning Payload Release10.1021/nn404166q ↗
20. An Overview of Nanoparticle Protein Corona Literature10.1002/smll.202301838 ↗
21. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy10.1021/acs.bioconjchem.0c00366 ↗
22. Protein Corona Formed on Lipid Nanoparticles Compromises Delivery Efficiency of mRNA Cargo10.1038/s41467-025-63726-2 ↗
23. Surface Hydrophobicity and Rigidity Determines Protein Corona on Orally Delivered Nanoparticles Treating Colitis10.1038/s41467-026-70453-9 ↗
24. Nanoparticle Elasticity Affects Systemic Circulation Lifetime by Modulating Adsorption of Apolipoprotein A‐I in Corona Formation10.1038/s41467-022-31882-4 ↗
25. Protein Corona of Anionic Fluid‐Phase Liposomes Compromises Their Integrity Rather than Uptake by Cells10.3390/membranes13070681 ↗
26. Evolution of the Nanoparticle Corona10.1038/nnano.2017.61 ↗
27. In Vivo Biomolecule Corona around Blood‐Circulating, Clinically Used and Antibody‐Targeted Lipid Bilayer Nanoscale Vesicles10.1021/acsnano.5b03300 ↗
28. Vascular Wall Shear Stress: Basic Principles and Methods
29. Influence of Dynamic Flow Environment on Nanoparticle‐Protein Corona: From Protein Patterns to Uptake in Cancer Cells10.1016/j.colsurfb.2017.02.037 ↗
30. Protein Corona in Response to Flow: Effect on Protein Concentration and Structure10.1016/j.bpj.2018.02.036 ↗
31. The Protein Corona of Circulating PEGylated Liposomes10.1016/j.bbamem.2015.11.012 ↗
32. The Biomolecular Corona of Nanoparticles in Circulating Biological Media10.1039/C5NR03701H ↗
33. Optimization of PLGA Nanoparticle Formulation via Microfluidic and Batch Nanoprecipitation Techniques10.3390/mi16090972 ↗
34. Dehydration‐Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes10.1038/nbt1184-979 ↗
35. Effects of Different Shear Rates on the Attachment and Detachment of Platelet Thrombi10.3892/mmr.2016.4825 ↗
36. Fluid Shear Stress Sensitizes Cancer Cells to Receptor‐Mediated Apoptosis via Trimeric Death Receptors10.1088/1367-2630/15/1/015008 ↗
37. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems10.3390/pharmaceutics10020057 ↗
38. Optimal Centrifugal Isolating of Liposome–Protein Complexes From Human Plasma10.1039/D1NA00211B ↗
39. Differential Cellular Responses to FDA‐Approved Nanomedicines: An Exploration of Albumin‐Based Nanocarriers and Liposomes in Protein Corona Formation10.1039/D3NR04862D ↗
40. S.Grumelot N.Mohammed J.Colonrosado et al. “Lipid Nanoparticle Protein Coronas Form via Lipoprotein Fusion Rather Than Shell‐Like Adsorption ”preprint bioRxivJune 23 2026 https://doi.org/10.64898/2025.12.21.695162.10.64898/2025.12.21.695162 ↗
41. Rapid Formation of Plasma Protein Corona Critically Affects Nanoparticle Pathophysiology10.1038/nnano.2013.181 ↗
42. Nanoscale Characterization of the Biomolecular Corona by Cryo‐Electron Microscopy, Cryo‐Electron Tomography, and Image Simulation10.1038/s41467-020-20884-9 ↗
43. Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting – Part I: In Vitro Release and Intracellular Uptake Perspective10.2147/IJN.S273713 ↗
44. Adsorption of Plasma Proteins on Uncoated PLGA Nanoparticles10.1016/j.ejpb.2012.11.030 ↗
45. The Lectin Pathway of the Complement System—Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems10.3390/ijms25031566 ↗
46. The Role of Ras‐Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?10.3390/biomedicines8090334 ↗
47. Mechanistic Understanding of In Vivo Protein Corona Formation on Polymeric Nanoparticles and Impact on Pharmacokinetics10.1038/s41467-017-00600-w ↗
48. Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines10.3389/fbioe.2020.599454 ↗
49. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles10.1021/acsnano.9b03824 ↗
50. Perfluorocarbon‐Loaded Poly(lactide‐co‐glycolide) Nanoparticles From Core to Crust: Multifaceted Impact of Surfactant on Particle Ultrastructure, Stiffness, and Cell Uptake10.1021/acsapm.4c03360 ↗
51. Effects of the Presence or Absence of a Protein Corona on Silica Nanoparticle Uptake and Impact on Cells10.1021/nn300223w ↗
52. The Protein Corona Leads to Deformation of Spherical Micelles10.1002/ange.202101129 ↗